Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zuliani, G.
Right arrow Articles by Korczyn, A.D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zuliani, G.
Right arrow Articles by Korczyn, A.D.
Related Collections
Right arrow Risk Factors
Right arrow Carotid Stenosis
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Genetics of cardiovascular disease

(Stroke. 2000;31:983-f.)
© 2000 American Heart Association, Inc.


Letters to the Editor

The A677V MTHFR Allele Is Not Associated With Carotid Atherosclerosis in Octogenarians

G. Zuliani, MD, PhD S. Volpato, MD, MPH

Department of Clinical and Experimental Medicine, Section of Internal Medicine II, University of Ferrara, Ferrara, Italy

P. Mecocci, MD, PhD A. Cherubini, MD

Gerontology and Geriatrics, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy

To the Editor:

We read with interest the article by Bova et al,1 published in the October 1999 issue of Stroke, on the association of the MTHFR A677V gene allele with carotid atherosclerosis. We have just finished a study aimed to characterize very old people with "vascular successful aging" (VSA), which we define according to the following criteria: (1) age >=75 years; (2) negative history for cardiovascular disease; (3) absence of clinical symptoms and ultrasonographic/Doppler signs (duplex sonography) of extracoronary (epiaortic, abdominal aortic, iliac, and femoral) atherosclerosis, ie, lack of any focal protrusion >=1.5 mm; and (4) absence of clinical symptoms and ECG signs of coronary artery disease. These subjects were compared with a control group selected by the following criteria: (1) age >=75 years and (2) presence of carotid atherosclerosis, ie, a plaque inducing a 30% to 50% stenosis. They may have a positive history for cardiovascular disease, provided that no acute episode occurred in the 3 months before inclusion in the study. A total of 57 subjects, 29 with VSA and 28 with carotid atherosclerosis (AG), were enrolled. The mean age in both groups was >80 years (80.9 and 81.8, respectively). We found several differences between the VSA subjects and controls in plasma and LDL antioxidant levels as well as in LDL oxidation level. Among the possible genetic markers of vascular successful aging, we also determined the A677V MTHFR gene polymorphism by the method of Frosst et al,2 but we did not find any association with the vascular status. The frequency of the A677V allele was 52% in the VSA group and 39% in the AG group ({chi}2=NS), while the frequency of homozygosity was 36% in VSA and 10% in the AG group ({chi}2=NS). Genotype frequencies conformed to the Hardy-Weinberg equilibrium. In the study of Bova et al, the subjects were significantly younger than in our study and the control group suffered from mild carotid atherosclerosis. Because atherosclerosis is a progressive disease, subjects with a mild stenosis in adult age, as the control group presented in the study, might develop greater stenosis in late life and therefore might not represent an ideal control for comparison. Moreover, only 19% of the subjects with severe carotid atherosclerosis were homozygous, a condition that has been clearly associated with increased homocysteine levels.2

Our results suggest that this polymorphism is not associated with the presence, or with the absence, of moderate to severe carotid atherosclerosis in very advanced age. However, it is possible that the A677V gene polymorphism is associated with atherosclerosis in a younger population as well as in different ethnic groups.

Because the relationship between A677V gene polymorphism and carotid atherosclerosis is still controversial,3 4 more research must be done in this field before any conclusion can be drawn.

References

1. Bova I, Chapman J, Sylantiev C, Korczyn AD, Bornstein NM. The A677V methylenetetrahydrofolate reductase gene polymorphysm and carotid atherosclerosis. Stroke.. 1999;30:2180–2182.[Abstract/Free Full Text]

2. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers CJH, den Heiljer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylentetrahydrofolate reductase. Nat Genet.. 1995;10:111–113. Letter.[Medline] [Order article via Infotrieve]

3. Kostulas K, Huang WX, Lannfelt L, Hagenfeldt L, Egertsen G. A methylentetrahydrofolate reductase gene polymorphysm in ischaemic stroke and in carotid artery stenosis. Eur J Clin Invest.. 1998;28:285–289.[Medline] [Order article via Infotrieve]

4. Spence JD, Malinow MR, Barnett PA, Marian AJ, Freeman D, Hegele RA. Plasma homocysteine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke.. 1999;30:969–973.[Abstract/Free Full Text]

Response

I. Bova, MD, PhD; C. Sylantiev, MD N.M. Bornstein, MD

Stroke Unit, Department of Neurology, Tel Aviv Sourasky Medical Center

J. Chapman, MD, PhD A.D. Korczyn, MD, MSc

Department of Neurology and, Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

We thank Zuliani and colleagues for describing their observations on carotid stenosis and the MTHFR 677c-t allele. As these authors note, their patient population was significantly older than the patients in our study and were chosen by somewhat different criteria. In this population the MTHFR 677c-t allele was less common in patients with moderate carotid stenosis than in age-matched patients with no significant cardiovascular disease. Although it is difficult to compare our study with the results of Zuliani et al, the differences between elderly and younger patients seem to be analogous with the well-established association of the APOE {epsilon}4 allele and Alzheimer’s disease. In the case of APOE, the {epsilon}4 allele is associated with earlier age of onset of disease; due to earlier mortality in Alzheimer’s disease, in the population aged >80 years it is no longer more common in Alzheimer patients than in controls.R1 R2

References

1. Scacchi R, De Bernardini L, Mantuano E, Donini LM, Vilardo T, Corbo RM. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer’s disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Neurosci Lett.. 1995;201:231–234.[Medline] [Order article via Infotrieve]

2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PCJ, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Tanzi RE, al e. Apolipoprotein E, survival in Alzheimer’s disease patients, and the competing risks of death and Alzheimer’s disease. Neurology.. 1995;45:1323–1328.[Abstract/Free Full Text]





This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zuliani, G.
Right arrow Articles by Korczyn, A.D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zuliani, G.
Right arrow Articles by Korczyn, A.D.
Related Collections
Right arrow Risk Factors
Right arrow Carotid Stenosis
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Genetics of cardiovascular disease